RT Journal Article
SR Electronic
T1 Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy
JF Neurology
JO Neurology
FD Lippincott Williams & Wilkins
SP 1735
OP 1738
DO 10.1212/WNL.51.6.1735
VO 51
IS 6
A1 Janine Louisa Good
A1 Mahan Chehrenama
A1 Richard Frederick Mayer
A1 Carol Lee Koski
YR 1998
UL http://n.neurology.org/content/51/6/1735.abstract
AB Fifteen patients with chronic inflammatory demyelinating neuropathy (CIDP) were treated with pulse intravenous cyclophosphamide (IVCY) monthly for up to 6 months. Eleven patients reached a complete remission; only one patient worsened. Complications included nausea, vomiting, anemia, and hair loss. This case series suggests that monthly IVCY is beneficial in the treatment of CIDP and warrants a controlled study.